Celesio AG reported earnings results for the nine months ended December 31, 2015. For the period, the company reported revenue from continuing operations of €16,227.8 million, EBIT of €331.9 million, adjusted EBIT of €343.5 million, Profit before taxes of €293.7 million, adjusted profit before taxes of €305.2 million, net profit of €202.9 million or €0.99 per share, adjusted net profit of €212.7 million or €1.03 per share, against revenue of €15,196.1 million, EBIT of €257.6 million, adjusted EBIT of €318.5 million, Profit before taxes of €208.9 million, adjusted profit before taxes of €269.8 million, net profit of €128.6 million or €0.64 per share, adjusted net profit of €183.7 million or €0.92 per share, a year ago. The revenue gain of an exclusive distribution contract with a major manufacturer in the United Kingdom and the volume growth in the British pharmacies more than offset the loss in revenue due to the loss of the hospital contract in Norway.

Thereby overall positive exchange rate effects amounted to €489.6 million, mainly related to the British pound sterling. Net debt increased from €897.0 million as of 31 March 2015 to €1,023.2 million as of 31 December 2015. Net profit and loss from continuing and discontinued operations came to €189.6 million compared to a net profit of €36.7 million a year ago.

Accordingly, basic and diluted earnings per share came to €0.92 compared to €0.18 a year ago.